Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Revance Therapeutics Inc RVNC

Healthcare
Revance Therapeutics, Inc. is a biotechnology company focused on developing and commercializing aesthetic and therapeutic offerings. The Company's portfolio includes DAXXIFY (DaxibotulinumtoxinA-lanm) for injection and the RHA Collection of dermal fillers in the United States. It has also partnered with Viatris to develop a biosimilar to onabotulinumtoxinA for injection and Fosun to... see more

Recent & Breaking News (NDAQ:RVNC)

RVNC INVESTOR ALERT: Investigation of Revance Therapeutics, Inc. Announced by Glancy Prongay & Murray LLP

Business Wire June 16, 2015

REVANCE THERAPEUTICS NOTICE: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Revance Therapeutics, Inc. to Contact the Firm

Marketwired June 12, 2015

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Laws Violations by the Board of Revance Therapeutics, Inc.

Business Wire June 11, 2015

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Revance Therapeutics, Inc. - RVNC

PR Newswire June 11, 2015

EQUITY ALERT: The Rosen Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Revance Therapeutics, Inc.

Business Wire June 10, 2015

Revance Therapeutics to Initiate Two Key Trials for RT001, Its Topical Botulinum Toxin Type A Investigational Drug Product Candidate

GlobeNewswire June 3, 2015

Revance to Participate in Upcoming Investor Conferences

GlobeNewswire May 21, 2015

Revance Therapeutics Releases First Quarter 2015 Financial Results

GlobeNewswire May 13, 2015

Revance Therapeutics to Release First Quarter 2015 Financial Results Wednesday, May 13, 2015

GlobeNewswire April 29, 2015

Revance Therapeutics Releases Fourth Quarter and Full Year 2014 Financial Results and Reiterates 2015 Outlook

GlobeNewswire March 2, 2015

Revance Appoints Dr. Philip Vickers to Its Board of Directors

GlobeNewswire February 26, 2015

Revance Therapeutics, Inc. Announces Participation in Cowen 35th Annual Health Care Conference

GlobeNewswire February 17, 2015

Revance Therapeutics to Release Fourth Quarter and Full Year 2014 Financial Results and Host Conference Call on Monday, March 2, 2015

GlobeNewswire February 12, 2015

Revance Therapeutics Defines Clinical Program Milestones and Provides Financial Guidance for 2015

GlobeNewswire January 12, 2015

Revance Therapeutics Announces Publication of Positive Results From RT002 Phase 1/2 Study

GlobeNewswire January 8, 2015

Revance Therapeutics Announces Initiation of BELMONT Phase 2 Active Comparator Trial of Injectable RT002

GlobeNewswire January 5, 2015

Revance Therapeutics Added to NASDAQ Biotechnology Index

GlobeNewswire December 18, 2014

Revance Therapeutics, Inc. Announces Participation in 26th Annual Piper Jaffray Healthcare Conference

GlobeNewswire November 20, 2014

Revance Therapeutics Releases Third Quarter 2014 Results

GlobeNewswire November 12, 2014

Revance Therapeutics, Inc. Announces Participation in Credit Suisse 2014 Healthcare Conference

GlobeNewswire November 4, 2014